Post by : Bianca
Haleem
PureHealth Holding has announced its financial results for the year ended 31 December 2025, reporting strong growth across its healthcare and insurance businesses. The company has also proposed a cash dividend of AED600 million for FY2025, subject to regulatory and shareholder approvals.
The Group reported revenue of AED27.3 billion in FY2025, marking a 5.7% year-on-year increase. This growth was supported by solid performance across its two key verticals: Healthcare (Care) and Insurance (Cover).
PureHealth’s EBITDA rose 16.1% compared to the previous year, reaching AED4.8 billion. The company said the improvement was driven by continued efficiency gains, synergies, and the contribution of Hellenic Healthcare Group (HHG) in Q4-2025. HHG was recently acquired and operates across Greece and Cyprus.
The company also posted strong profitability. Net profit increased 17.7% year-on-year to AED2 billion, while pretax profit rose 26.1% to AED2.2 billion.
Based on this performance, PureHealth proposed distributing AED600 million in dividends, which is equal to around 30% of net profit. The dividend is planned to be paid in two equal semiannual instalments.
PureHealth said the proposed dividend reflects the strength of its balance sheet, recurring earnings, and sustainable cash generation across market cycles. The company also highlighted that its dividend framework supports long-term growth while maintaining disciplined capital allocation.
PureHealth currently operates across the UAE, the USA, the UK, Greece, and Cyprus. The company said it is supported by rising patient volumes, expanded clinical capacity, specialised services, and continued investment in AI-enabled healthcare delivery.
Commenting on the results, Kamal Al Maazmi, Chairman of PureHealth, said 2025 was an important year for the company’s ambition to build a global technology-enabled healthcare group. He added that the proposed dividend policy reflects the Board’s confidence in PureHealth’s financial strength and its commitment to sustainable shareholder value.
Farhan Malik, Founder and Managing Director, said the company’s resilient performance and strong balance sheet support disciplined investment in technology, AI, capacity expansion, and value-accretive acquisitions. He added that around 50% of PureHealth’s assets are now outside the UAE, making it an international business with diversified revenues across markets and currencies.
Shaista Asif, Group Chief Executive Officer, said PureHealth’s Care and Cover model is delivering resilient earnings, strong cash generation, and synergies across multiple markets. She also highlighted growth in the UAE, improved financial performance in the UK through Circle Health Group, and the successful HHG acquisition in Greece and Cyprus. She added that PureHealth’s digital solutions and AI deployment are helping build a distinctive platform for the future of healthcare.
English
